| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| Aileron Therapeutics (ALRN) | BofA Merrill Lynch/ Jefferies | $69.00 | n.a. | |||
| Bison Capital Acquisition (BCACU) (u) | EarlyBirdCapital | 5.00 | $10.00 | $10.00 | $50.00 | n.a. |
| Blue Apron Holdings (APRN) | Goldman Sachs/ Morgan Stanley/ Citigroup/ Barclays | $100.00 | n.a. | |||
| Byline Bancorp (BY) | BofA Merrill Lynch/ Keefe, Bruyette & Woods (A Stifel Company) | $75.00 | n.a. | |||
| Dova Pharmaceuticals (DOVA) | J.P. Morgan/ Jefferies/ Leerink Partners | $74.75 | n.a. | |||
| Esquire Financial Holdings (ESQ) | Sandler O’Neill & Partners | $40.25 | n.a. | |||
| Hennessy Capital Acquisition Corp. III (HCAC.U) (u) | Credit Suisse/ Stifel | 22.50 | $10.00 | $10.00 | $225.00 | n.a. |
| Mersana Therapeutics (MRSN) | J.P. Morgan/ Cowen/ Leerink Partners | $75.00 | n.a. | |||
| Tintri (TNTR) | Morgan Stanley/ BofAMerrill Lynch/ Pacific Crest Securities (a division of KeyBanc Capital Markets) | $100.00 | n.a. | |||
| n.a. (not available) | ||||||
| u (unit offering) | ||||||
| Postponed | ||||||
| Immuron Ltd (IMRN) | Joseph Gunnar & Co.Joseph Gunnar & Co./ Rodman & Renshaw (a unit of H.C. Wainwright & Co. | 0.78 | $10.00 | $12.50 | $8.75 | N/C |
| Immuron Ltd (IMRNW) | Joseph Gunnar & Co.Joseph Gunnar & Co./ Rodman & Renshaw (a unit of H.C. Wainwright & Co. | 0.39 | $0.01 | $0.01 | $0.00 | N/C |
| N/C = No Call – Stock is traded on the Australian Securities Exchange | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| Athenex (ATNX) | Credit Suisse/ J.P. Morgan | 6.00 | $11.00 | $13.00 | $72.00 | S/O |
| Dole Food Company (TBA) | Morgan Stanley/ BofA Merrill Lynch/ Deutsche Bank Securities/ RBC Capital Markets | $100.00 | S/O | |||
| Newater Technology (NEWA) | ViewTrade Securities | 1.40 | $4.00 | $5.00 | $6.30 | S/O |
| TPG RE Finance Trust (TRTX) | BofA Merrill Lynch/ Citigroup/ Goldman, Sachs/ Wells Fargo Securities/ Deutsche Bank Securities/ Morgan Stanley/ Barclays | $100.00 | S/O | |||
| S/O (Subscribers Only) | ||||||
| TBA (to be announced) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of May 29, 2017 | Manager(s) | Offered | Raised | Price | 6/2/17 | Change |
| KBL Merger Corp. IV (KBLMU) (u) | Ladenburg Thalmann | 10.00 | $100.00 | $10.00 | $10.00 | 0.00% |
| u (unit offering) | ||||||
